New antimicrobial drugs effective against multidrug-resistant bacteria

The RESIST project, in which GAIKER participates, will develop new drugs based on nanoparticles to combat infections caused by multiresistant and difficult to treat bacteria. Antimicrobial resistance (AMR), or the ability of a microorganism not to respond to the action of an antimicrobial agent, is currently a serious problem facing public health worldwide. The World…